Thomas J. Lamb – Law Offices of Thomas J. Lamb, P.A.

Drug Injury Watch: Diabetes Drugs Bydureon And Victoza: Thyroid Cancer Label Change In March 2015 Comes Without Much Notice

Drug Injury Watch: Diabetes Drugs Bydureon And Victoza: Thyroid Cancer Label Change In March 2015 Comes Without Much Notice FDA Letters To AstraZeneca And Novo Nordisk Approve Addition Of Information About Increased Risk For…more
|

Drug Injury Watch: YAZ / Yasmin Litigation Update For March 2015: According To Bayer's 2014 Annual Report, "Additional lawsuits are anticipated."

Drug Injury Watch: YAZ / Yasmin Litigation Update For March 2015: According To Bayer's 2014 Annual Report, "Additional lawsuits are anticipated." Bayer Claims It Settled About 300 Of These Cases While Another 1300 Lawsuits…more
|

Drug Injury Watch: Cardiovascular Safety Issues For Onglyza And Kombiglyze Will Be Discussed At April 2015 FDA Advisory Committee Meeting

Drug Injury Watch: Cardiovascular Safety Issues For Onglyza And Kombiglyze Will Be Discussed At April 2015 FDA Advisory Committee Meeting These Two New AstraZeneca Diabetes Medications With Saxagliptin Are Part Of The…more
|

First 2015 Update On Fosamax Femur Fracture Litigation: Not Much New Information To Report Out

First 2015 Update On Fosamax Femur Fracture Litigation: Not Much New Information To Report Out With New Jersey State Court Fosamax Lawsuits Now Assigned To Judge Mayer, We Hope These Cases Get Back On…more
|

A New Case Of Progressive Multifocal Leukoencephalopathy (PML) In A Patient Using Gilenya Is Reported By Novartis In Canada

A New Case Of Progressive Multifocal Leukoencephalopathy (PML) In A Patient Using Gilenya Is Reported By Novartis In Canada Company Is Investigating This Gilenya - PML Case To See Whether Brain Disease Might Be A Side Effect…more
|

Drug Injury Watch: Various Drug Safety Issues Continue To Be Associated With Novartis Multiple Sclerosis (MS) Medication Gilenya

Drug Injury Watch: Various Drug Safety Issues Continue To Be Associated With Novartis Multiple Sclerosis (MS) Medication Gilenya ISMP QuarterWatch Report From 2014 States Adverse Events Reports Show That Gilenya Cardiac Risks…more
|

Drug Injury Watch: Zofran Associated With Birth Defects When Used During Pregnancy As An "Off-Label" Morning Sickness Treatment

Drug Injury Watch: Zofran Associated With Birth Defects When Used During Pregnancy As An "Off-Label" Morning Sickness Treatment Medical Researchers Find Increased Risk Of Heart Defects And Cleft Palates In Babies Born To…more
|

Drug Injury Watch: Viagra / Cialis / Levitra: Prostate Cancer Recurrence When Used After Radical Prostatectomy Surgery

Drug Injury Watch: Viagra / Cialis / Levitra: Prostate Cancer Recurrence When Used After Radical Prostatectomy Surgery Researchers Surprised By Their Finding As Earlier Medical Studies Suggested Anticancer Effect In…more
|

Drug Injury Watch: UK Drug Safety Regulator Issues New Warnings About The Use Of Depakote / Depacon / Depakene By Women During Pregnancy

Drug Injury Watch: UK Drug Safety Regulator Issues New Warnings About The Use Of Depakote / Depacon / Depakene By Women During Pregnancy Updates Information About Extent Of Serious Developmental Disorders Such As Autism…more
|

Drug Injury Watch: Pancreatic Cancer As A Side Effect Of Diabetes Drugs Bydureon, Byetta, Januvia, And Victoza

Drug Injury Watch: Pancreatic Cancer As A Side Effect Of Diabetes Drugs Bydureon, Byetta, Januvia, And Victoza Health Canada Currently Conducting Epidemiological Study Of These Incretin-Based Type 2 Diabetes Medications To…more
|

Drug Injury Watch: A French Medical Study Provides More Support For Apparent Link Between Benicar With Chronic Severe Diarrhea And Substantial Weight Loss Side Effects

Drug Injury Watch: A French Medical Study Provides More Support For Apparent Link Between Benicar With Chronic Severe Diarrhea And Substantial Weight Loss Side Effects Researchers Found An Almost 10-Times Increased Risk Of…more
|

Drug Injury Watch: Cialis / Levitra / Viagra - Melanoma: Possible Drug Safety Issue Was Raised And Left Open In A 2011 Medical Journal Article

Drug Injury Watch: Cialis / Levitra / Viagra - Melanoma: Possible Drug Safety Issue Was Raised And Left Open In A 2011 Medical Journal Article Erectile Dysfunction (ED) Drugs And Pulmonary Arterial Hypertension (PAH)…more
|

Drug Injury Watch: Xolair Is Associated With Higher Than Expected Reporting Of Arterial Thrombotic Events Such As Strokes And Cardiovascular Deaths

Drug Injury Watch: Xolair Is Associated With Higher Than Expected Reporting Of Arterial Thrombotic Events Such As Strokes And Cardiovascular Deaths While European Drug Regulators Have Been Concerned About T his Aspect Of…more
|

Drug Injury Watch: Eliquis Antidote Will Come Too Late For People Who Suffered Serious Bleeding Events, Some Which Caused The Deaths Of Patients

Drug Injury Watch: Eliquis Antidote Will Come Too Late For People Who Suffered Serious Bleeding Events, Some Which Caused The Deaths Of Patients Advertisements As Well As Prescribing Information / Drug Label Seem To Downplay…more
|

Drug Injury Watch: December 2014 YAZ / Yasmin Litigation Update: Still Over 2000 DVT And/Or PE Cases Not Settled According To Bayer's Most Recent Financial Report

Drug Injury Watch: December 2014 YAZ / Yasmin Litigation Update: Still Over 2000 DVT And/Or PE Cases Not Settled According To Bayer's Most Recent Financial Report And New Blood Clot Side Effect Lawsuits, Including Some…more
|
Showing 1-15 of 387 Results
|
View per page
Page: of 26
Contact

Lumina Station, Suite 225 1908 Eastwood Road
Wilmington, NC 28403, United States

  • (910) 256-2971
  • (910) 256-2972

Areas of Practice
  • Personal Injury
  • Products Liability
  • Professional Malpractice
  • Toxic Torts
This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.
×